Kojin is pioneering cell-state and ferroptosis biology and cutting-edge drug discovery to develop first-in-class small-molecule treatments that modulate ferroptosis.

Biotechnology

Kojin Therapeutics

Kojin Therapeutics' headquarters in Boston, MA, United States

Harvey J. Berger

Sean Morrison

Stuart Schreiber

Stephanie Dougan

Joel Barrish

George Demetri

Steven Davidsen

Morris J. Birnbaum

Benjamin Cravatt

Benjamin Neel

Eric de La Fortelle

Christina Vorvis

Fabio Pucci

Amir Nashat

AJ Ferraro

Steven Neier

Eric Winer

Kojin Therapeutics' CEO and Executive Team includes Kay Ahn and 1 others.

CEO and Executive Team

About

People (2)

Harvey J. Berger

Wei-Sheng Huang

Jobs